“The promise of patient convenience without the extra burden has won Bright.md a growing fan club among hospitals and medical groups.
- AVIA Innovator Network

“New telepresence doctor visits from companies like ... Bright.md deliver house calls via your mobile phone or computer, eliminating the need for the elderly to travel to a doctor.
- HuffPost

“Before you actually talk to your doctor, [SmartExam] gathers basic data. The app dynamically adapts the questions according to your answers. Using AI, it will give your doctor a preliminary diagnosis treatment plan.
- Wired

“Thank you, thank you. I was able to get relief so much faster than driving to a clinic. The instructions were thorough and easy to understand. This is smart health care.
- Adventist Patient, 2018

“I have never been more excited about healthcare. We have six kids; it would be a nightmare to find sitters, wait at the office and for prescriptions. I did not feel like getting dressed let alone leaving the house! This is ingenious!
- Patient, Greenville Health System, 2018

“Very fast and effective way to get treated without going to a doctor's office and waiting. It only took about 15 minutes from the time I started the exam to get medications called into my pharmacy.
- Patient, Palmetto Health 2018

“I live 85 miles from my doctor. This service saved a long trip and I was treated properly.
- Patient, Presbyterian Health, 2018

“It was so convenient and easy to use. I didn't have to take time off work or get extra tests that were not needed. I had no waiting in a waiting room full of sick people and was able to pick my prescription up right after work. Awesome!
- Patient, Presbyterian Health, 2018

“I trust SmartExam. It never gets in a hurry. It’s the same on Monday as it is on Thursday.”
- Bright.md partner provider

“My favorite thing about SmartExam is the ability to access it from anywhere with an internet connection.”
- Provider, Providence Health Systems, 2018

“SmartExam is being used by health systems to offer 24/7 access to care for more than 470 common medical conditions.”
- The Wall Street Journal, 2019

← Back to In the News

March 18, 2020

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

Share

PALO ALTO, Calif.--(BUSINESS WIRE)--StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders, announces the launch of its StartX Med COVID-19 Task Force and the mobilization of its breakthrough medical companies providing solutions for the prevention, diagnostics and treatment of the novel coronavirus. The group of leading scientists, physicians and professor entrepreneurs will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health.

Among the many leading-edge biotech, medical device and digital health companies solving critical needs during the COVID-19 pandemic are physicians working with positive cases, companies with FDA cleared solutions and those that are on the fast-track with the CDC. The following are a few ways the StartX Med COVID-19 Task Force is working to provide hope, flatten the curve, and combat the novel coronavirus:

  • Rapid tests suitable for drive through testing, nursing homes, and ER rooms with results in 10 minutes
  • Applications and hardware to assess respiratory issues
  • Rapid solutions to fight developing sepsis and correlating antibiotic resistance resulting from COVID-19 severe complications
  • COVID-19 related applications for remotely monitoring quarantined patients and healthcare workers who have been exposed
  • Rapid RNA testing technologies
  • Testing that provides information on the presence, type and severity of infections
  • Solutions for optimizing hospital operations and supply chain tracking
  • Solutions for automated quarantine management and remote virtual triage
  • A centrifuge system which is readily deployable for remote sample collection and prep
  • A handheld device measuring temperature, lung sounds, airway pressure, pulmonary function, ECG, and SPO2
  • Remote monitoring for respiratory diseases, and other StartX Med technologies already deployed in Wuhan, China
  • Free access to the Bioz research platform for biopharma companies
  • Free virtual COVID-19 evaluation, screening and escalation tool for any hospital in the U.S. to help preserve clinical resources for patients who warrant in-person care
  • StartX Med therapeutics companies with new antiviral drugs to treat COVID-19 and the most common lung disease caused by it, Acute Respiratory Distress Syndrome (ARDS), are accelerating their efforts to take their treatments into clinical settings.

“One of our first goals would be for existing StartX genetics companies to be able to ramp-up their current solutions for molecular testing of COVID-19 diagnostics and work with local and state officials and government agencies on deployment,” stated Dr. Michael Niaki, StartX Med COVID-19 Task Force Lead for the Diagnostics Subgroup.

Current StartX Med COVID-19 Task Force Participants include:

Prevention: DawnLight Technologies - Luma Health - Mon Ami - Theranova - Tueo - Qventus

Diagnostics: Avails Medical - Eko - Enable Biosciences - Inflammatix - Lucira Health - Magnetic Insight Mendo - Nirmidas Biotech, Inc. - ProbiusDx - Sandstone Diagnostics - Sensio Air - Sentinel Healthcare - Spire Health - Subtle Medical - Quantumcyte

Treatment: Augmedix - Bioz - Bright.md - Chimera Bio - GEn1E - Globavir BioSciences - Guided Clarity - InfiniGene - KangarooHealth - OMNY - Orcabio - Parzival - Potrero - Qventus - Spot Biosystems - Line Up Health - Wellsheet

“As the number of positive cases continue to soar in the outbreak of COVID-19, there is an imminent need for reducing barriers companies are experiencing with therapeutic medical breakthroughs needing to be deployed,” stated Joseph Huang, CEO of StartX. “We’ve always said that our community of industry leaders can achieve more as a group than as individuals and this is a prime example of how quickly StartX companies and the Stanford entrepreneurship ecosystem can mobilize and come together in times of crisis.”

In addition to partnering in outreach to government agencies and public health offices for immediate deployment of life-saving medical solutions, the coalition will offer investors a special COVID-19 Task Force version of StartX’s Online Investor Demo Day viewings to coordinate introductions between StartX Med companies tackling COVID-19 and VCs specifically interested in investing in this space. Both StartX's General Investor Demo Day and COVID-19 specific viewings are slated to begin March 19, 2019.

Business Wire

Learn how Bright.md's virtual care solutions can help your system manage the COVID-19 crisis and deliver high-quality care for hundreds of conditions every day.

Contact Bright.md to schedule a demo and experience the product from all perspectives.

Bright.md

510 SW 3rd Ave
Suite 300
Portland, OR 97204

877.888.5242
jr@bright.md